Assembly Biosciences, Inc. (ASMB) Misses Q1 EPS by $1.39
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ASMB Hot Sheet
Join SI Premium – FREE
Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q1 EPS of ($1.66), $1.39 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $5.79 million.
For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Assembly Biosciences (ASMB) PT Lowered to $48 at UBS
- Walmart stock climbs on AI shopping tool expansion
- Netflix gains after Ackman endorsement and AI feature launch
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
